Octapharma has announced that, for the first time in almost 30 years, NHS patients are receiving medicines made from ...

NICE’s interim second draft guidance does not recommend lecanemab for use within the NHS in England and Wales at this time.

To reduce waiting lists and enhance patient communication, Rotherham NHS Foundation Trust has adopted Netcall’s Liberty for ...

The Safety Review Committee (SRC) has confirmed the end of the Dose Escalation phase and the start of the cohort expansion ...

Centauri Therapeutics Limited has announced the selection of its first clinical candidate for the ABX-01 programme. The ...

Kenvue has appointed Bas Vorsteveld as Area Managing Director for Northern Europe. He will oversee Kenvue’s business in the ...

Research from the Blood Cancer Alliance reveals a significant disparity in access to new blood cancer treatments on the NHS.

Grünenthal has announced that Professor Dr Uli Brödl will assume the role of Chief Scientific Officer (CSO) and Member of the ...

At its core, the regulation aims to improve transparency and accountability in clinical trials across Europe. For ...

Entering the post-approval phase marks a critical pivot for pharmaceutical companies, shifting their focus from the ...

Datapharm, a UK-based provider of medicines information, has announced its expansion into Europe through a strategic partnership with VIDAL. This collaboration will make Datapharm’s Scientific ...

Brainomix, a leader in stroke AI imaging software, has announced a strategic partnership with Medtronic Neurovascular to improve stroke care across Western Europe. The collaboration seeks to integrate ...